Altria Group, Inc. (MO)
Why Altria (MO) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Altria (MO) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Exploring Analyst Estimates for Altria (MO) Q2 Earnings, Beyond Revenue and EPS
Evaluate the expected performance of Altria (MO) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Dividend Harvesting Portfolio Week 229: $22,900 Allocated, $2,412.94 In Projected Dividends
The Dividend Harvesting Portfolio hit new all-time highs, delivering a 29.44% return and $2,412.94 in forward annual dividend income. Consistent reinvestment and sector diversification have created a strong compounding effect, with the portfolio now yielding 8.14% and averaging $201.08 in monthly dividends. I see significant upside ahead, especially as technology earnings expand and a potential Fed pivot boosts REITs and financials.
Altria Q2 Preview: An Equity Bond With 12% Yield
Based on the lasted earnings projections, Altria Group, Inc. stock is like an equity bond with a 12% yield in my model. With the EPS revisions for its FQ2, MO's EBT (earnings before taxes) multiple is only 8.39x, translating a 12% EBT yield. Earnings consistency, 55 years of dividend growth, and a safe payout ratio reinforce MO's defensive and quasi-bond appeal.
Altria (MO) Reports Next Week: Wall Street Expects Earnings Growth
Altria (MO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is on! the Bright Spot in Altria's Oral Tobacco Portfolio?
With rising brand loyalty and expanding reach, on! is reshaping MO's future in the oral nicotine space.
Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know
Altria (MO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
A 55-Year Dividend Stock With A Soaring Share Price
Altria (NYSE: MO) is the leading seller of cigarettes and smokeless tobacco in the US.
3 Reasons Why Altria's A Buy
In a year that tobacco stocks have been on the up and up, Altria has been a relative laggard. There's a good reason for it too: it's challenges in making inroads into the vaping market. For now, though, its projected earnings growth and attractive forward P/E and forward dividend yield compared with peers work in its favour.
FDA approves sales of Juul's e-cigarettes in the US
The US Food and Drug Administration (FDA) has approved the sale of Juul's e-cigarette device and its refill cartridges in tobacco and menthol flavors. The Washington, DC-based private firm said on Thursday the FDA has determined its products are "appropriate for the protection of public health,” meeting the statutory requirement for introducing new tobacco products onto the US market.
Are Consumer Staples Stocks Lagging Altria Group (MO) This Year?
Here is how Altria (MO) and Carlsberg AS (CABGY) have performed compared to their sector so far this year.
